Atherosclerosis
3 competing products in clinical development for Atherosclerosis.
Pipeline by Phase
Phase 21
Phase 2/31
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Olmesartan medoxomil + Placebo | Daiichi Sankyo | Phase 3 | Completed | 40 |
| Pactimibe | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Pactimibe sulfate | Daiichi Sankyo | Phase 2/3 | Terminated | 30 |